Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Clinical trial NCT00856206 · COMPLETED
Trial details
- NCT number
- NCT00856206
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-01-01
- Enrollment
- 1315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.